Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Clinical trial NCT03778931 · COMPLETED
Trial details
- NCT number
- NCT03778931
- Sponsor
- Stemline Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-10
- Primary completion
- 2021-08-24
- Enrollment
- 478
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.